1. Home
  2. DAC vs CRVS Comparison

DAC vs CRVS Comparison

Compare DAC & CRVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Danaos Corporation

DAC

Danaos Corporation

HOLD

Current Price

$105.72

Market Cap

1.7B

ML Signal

HOLD

Logo Corvus Pharmaceuticals Inc.

CRVS

Corvus Pharmaceuticals Inc.

HOLD

Current Price

$19.26

Market Cap

1.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DAC
CRVS
Founded
1972
2014
Country
Greece
United States
Employees
N/A
N/A
Industry
Marine Transportation
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.7B
1.7B
IPO Year
2006
2016

Fundamental Metrics

Financial Performance
Metric
DAC
CRVS
Price
$105.72
$19.26
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
5
Target Price
$105.00
$28.00
AVG Volume (30 Days)
74.8K
7.7M
Earning Date
02-09-2026
03-24-2026
Dividend Yield
3.43%
N/A
EPS Growth
2.73
N/A
EPS
26.76
N/A
Revenue
$1,042,456,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$3.92
N/A
Revenue Growth
2.79
N/A
52 Week Low
$65.40
$2.54
52 Week High
$107.60
$26.95

Technical Indicators

Market Signals
Indicator
DAC
CRVS
Relative Strength Index (RSI) 67.89 59.28
Support Level $99.99 $18.92
Resistance Level $107.60 $21.57
Average True Range (ATR) 2.36 1.73
MACD 0.09 -0.53
Stochastic Oscillator 76.87 10.30

Price Performance

Historical Comparison
DAC
CRVS

About DAC Danaos Corporation

Danaos Corp is an international owner of containerships. It provides international seaborne transportation services by operating vessels in the containership sector of the shipping industry. The company's customers include, HMM, MSC, Yang Ming, Hapag Lloyd, ZIM, Maersk, COSCO, OOCL, ONE, PIL, Sealead, Niledutch, Samudera, OSC, and Arkas. Geographically, the company operates in Australia-Asia, Europe, and America, with maximum revenue from the Australia-Asia region. It has two reporting segments Container vessels and Drybulk vessels segment. It generates the majority of its revenue from Container vessels.

About CRVS Corvus Pharmaceuticals Inc.

Corvus Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing product candidates that precisely target proteins that are critical to immune cell maturation and function. Its product candidate, soquelitinib, is designed to bind specifically to a protein, interleukin 2 inducible T cell kinase (ITK), involved in T cell activation, T cell receptor signaling and T cell differentiation and function. The other products include Ciforadenant (CPI-444) and Mupadolimab (CPI-006).

Share on Social Networks: